6533b7dbfe1ef96bd1270d02

RESEARCH PRODUCT

Air pollution and stroke. A new modifiable risk factor is in the air

Anne-sophie MarietGauthier DuloquinLaura BaptisteChristelle Blanc-labarreSophie MohrMathilde GraberM. GiroudYannick Béjot

subject

medicine.medical_specialty[SDV]Life Sciences [q-bio]Air pollutionComorbiditymedicine.disease_causeEffect Modifier Epidemiologic03 medical and health sciences0302 clinical medicineRisk FactorsEnvironmental healthAir PollutionEpidemiologymedicineHumanscardiovascular diseases030212 general & internal medicineMyocardial infarctionRisk factorStrokeInhalation Exposurebusiness.industryPublic healthMortality ratemedicine.disease3. Good healthStrokeNeurologyLow and middle income countriesIschemic Attack TransientParticulate MatterNeurology (clinical)business030217 neurology & neurosurgery

description

Abstract Evidence from epidemiological studies has demonstrated that outdoor air pollution is now a well-known major problem of public health, mainly in low and middle income countries. Contrasting with myocardial infarction , there are few data on the association of air pollution and stroke. Methods We propose a narrative literature review of the effects and the underlying biological mechanisms of short- and long-term exposure to air pollutants on stroke risk and mortality, using the following key-words: stroke, cerebrovascular events, ischemic and haemorrhage stroke, transient ischaemic attack , mortality, air pollution and air pollutants. Results Twenty-one papers were selected. Air pollution, of which whose small particulate matter are the most toxic, contributes to about one-third of the global burden of stroke. We can identify vulnerable patients with classical neuro-vascular risk factors or a prior history of stroke or transient ischemic attack or persons living in low-income countries. Biological mechanisms of this new morbid association are discussed. Conclusion Air pollution should be recognized as a silent killer inducing stroke whose mortality rates remain elevated by its role as a new modifiable neurovascular risk factor, needing public health policies .

10.1016/j.neurol.2019.03.003https://hal.archives-ouvertes.fr/hal-03488515/document